Surgery in severe valvular heart diseases: when it is too late, too early or right on time?
- PMID: 36349942
- DOI: 10.2459/JCM.0000000000001364
Surgery in severe valvular heart diseases: when it is too late, too early or right on time?
Comment on
-
Myocardial fibrosis in asymptomatic patients undergoing surgery for mitral and aortic valve regurgitation.J Cardiovasc Med (Hagerstown). 2022 Aug 1;23(8):505-512. doi: 10.2459/JCM.0000000000001347. J Cardiovasc Med (Hagerstown). 2022. PMID: 35904996
References
-
- Murtha LA, Schuliga MJ, Mabotuwana NS, et al. The processes and mechanisms of cardiac and pulmonary fibrosis. Front Physiol 2017; 8:777.
-
- Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006; 368:1005–1011.
-
- Iung B, Delgado V, Rosenhek R, et al. Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart disease II survey. Circulation 2019; 140:1156–1169.
-
- Mozaffarian D, Benjamin EJ, Go AS, et al. Writing Group Members. Executive summary: heart disease and stroke statistics – 2016 update: a report from the American Heart Association. Circulation 2016; 133:447–454.
-
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43:561–632.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
